table of content
1 Introduction to Research & Analysis Reports
1.1 Natural Killer Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Natural Killer Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Natural Killer Cell Therapy Overall Market Size
2.1 Global Natural Killer Cell Therapy Market Size: 2022 VS 2029
2.2 Global Natural Killer Cell Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Natural Killer Cell Therapy Players in Global Market
3.2 Top Global Natural Killer Cell Therapy Companies Ranked by Revenue
3.3 Global Natural Killer Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 Natural Killer Cell Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Natural Killer Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Natural Killer Cell Therapy Players in Global Market
3.6.1 List of Global Tier 1 Natural Killer Cell Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Natural Killer Cell Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Natural Killer Cell Therapy Market Size Markets, 2022 & 2029
4.1.2 NK Cell Therapies
4.1.3 NK Cell Directed Antibodies
4.2 By Type - Global Natural Killer Cell Therapy Revenue & Forecasts
4.2.1 By Type - Global Natural Killer Cell Therapy Revenue, 2018-2023
4.2.2 By Type - Global Natural Killer Cell Therapy Revenue, 2024-2029
4.2.3 By Type - Global Natural Killer Cell Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Natural Killer Cell Therapy Market Size, 2022 & 2029
5.1.2 Cancer
5.1.3 Gastrointestinal Diseases
5.1.4 Others
5.2 By Application - Global Natural Killer Cell Therapy Revenue & Forecasts
5.2.1 By Application - Global Natural Killer Cell Therapy Revenue, 2018-2023
5.2.2 By Application - Global Natural Killer Cell Therapy Revenue, 2024-2029
5.2.3 By Application - Global Natural Killer Cell Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Natural Killer Cell Therapy Market Size, 2022 & 2029
6.2 By Region - Global Natural Killer Cell Therapy Revenue & Forecasts
6.2.1 By Region - Global Natural Killer Cell Therapy Revenue, 2018-2023
6.2.2 By Region - Global Natural Killer Cell Therapy Revenue, 2024-2029
6.2.3 By Region - Global Natural Killer Cell Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Natural Killer Cell Therapy Revenue, 2018-2029
6.3.2 US Natural Killer Cell Therapy Market Size, 2018-2029
6.3.3 Canada Natural Killer Cell Therapy Market Size, 2018-2029
6.3.4 Mexico Natural Killer Cell Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Natural Killer Cell Therapy Revenue, 2018-2029
6.4.2 Germany Natural Killer Cell Therapy Market Size, 2018-2029
6.4.3 France Natural Killer Cell Therapy Market Size, 2018-2029
6.4.4 U.K. Natural Killer Cell Therapy Market Size, 2018-2029
6.4.5 Italy Natural Killer Cell Therapy Market Size, 2018-2029
6.4.6 Russia Natural Killer Cell Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Natural Killer Cell Therapy Market Size, 2018-2029
6.4.8 Benelux Natural Killer Cell Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Natural Killer Cell Therapy Revenue, 2018-2029
6.5.2 China Natural Killer Cell Therapy Market Size, 2018-2029
6.5.3 Japan Natural Killer Cell Therapy Market Size, 2018-2029
6.5.4 South Korea Natural Killer Cell Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Natural Killer Cell Therapy Market Size, 2018-2029
6.5.6 India Natural Killer Cell Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Natural Killer Cell Therapy Revenue, 2018-2029
6.6.2 Brazil Natural Killer Cell Therapy Market Size, 2018-2029
6.6.3 Argentina Natural Killer Cell Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Natural Killer Cell Therapy Revenue, 2018-2029
6.7.2 Turkey Natural Killer Cell Therapy Market Size, 2018-2029
6.7.3 Israel Natural Killer Cell Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Natural Killer Cell Therapy Market Size, 2018-2029
6.7.5 UAE Natural Killer Cell Therapy Market Size, 2018-2029
7 Natural Killer Cell Therapy Companies Profiles
7.1 Nektar Therapeutics
7.1.1 Nektar Therapeutics Company Summary
7.1.2 Nektar Therapeutics Business Overview
7.1.3 Nektar Therapeutics Natural Killer Cell Therapy Major Product Offerings
7.1.4 Nektar Therapeutics Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.1.5 Nektar Therapeutics Key News & Latest Developments
7.2 Innate Pharma SA
7.2.1 Innate Pharma SA Company Summary
7.2.2 Innate Pharma SA Business Overview
7.2.3 Innate Pharma SA Natural Killer Cell Therapy Major Product Offerings
7.2.4 Innate Pharma SA Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.2.5 Innate Pharma SA Key News & Latest Developments
7.3 Affimed
7.3.1 Affimed Company Summary
7.3.2 Affimed Business Overview
7.3.3 Affimed Natural Killer Cell Therapy Major Product Offerings
7.3.4 Affimed Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.3.5 Affimed Key News & Latest Developments
7.4 Chipscreen Biosciences
7.4.1 Chipscreen Biosciences Company Summary
7.4.2 Chipscreen Biosciences Business Overview
7.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Major Product Offerings
7.4.4 Chipscreen Biosciences Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.4.5 Chipscreen Biosciences Key News & Latest Developments
7.5 Glycostem Therapeutics
7.5.1 Glycostem Therapeutics Company Summary
7.5.2 Glycostem Therapeutics Business Overview
7.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Major Product Offerings
7.5.4 Glycostem Therapeutics Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.5.5 Glycostem Therapeutics Key News & Latest Developments
7.6 Fate Therapeutics
7.6.1 Fate Therapeutics Company Summary
7.6.2 Fate Therapeutics Business Overview
7.6.3 Fate Therapeutics Natural Killer Cell Therapy Major Product Offerings
7.6.4 Fate Therapeutics Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.6.5 Fate Therapeutics Key News & Latest Developments
7.7 Dragonfly Therapeutics
7.7.1 Dragonfly Therapeutics Company Summary
7.7.2 Dragonfly Therapeutics Business Overview
7.7.3 Dragonfly Therapeutics Natural Killer Cell Therapy Major Product Offerings
7.7.4 Dragonfly Therapeutics Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.7.5 Dragonfly Therapeutics Key News & Latest Developments
7.8 Kiadis Pharma
7.8.1 Kiadis Pharma Company Summary
7.8.2 Kiadis Pharma Business Overview
7.8.3 Kiadis Pharma Natural Killer Cell Therapy Major Product Offerings
7.8.4 Kiadis Pharma Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.8.5 Kiadis Pharma Key News & Latest Developments
7.9 Nkarta Therapeutics
7.9.1 Nkarta Therapeutics Company Summary
7.9.2 Nkarta Therapeutics Business Overview
7.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Major Product Offerings
7.9.4 Nkarta Therapeutics Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.9.5 Nkarta Therapeutics Key News & Latest Developments
7.10 NantKwest
7.10.1 NantKwest Company Summary
7.10.2 NantKwest Business Overview
7.10.3 NantKwest Natural Killer Cell Therapy Major Product Offerings
7.10.4 NantKwest Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.10.5 NantKwest Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
